DLS

Steakholder Foods Reports 2023 Financial Results and Provides Business Update

Retrieved on: 
Tuesday, April 30, 2024
Net, Tuna, Memorandum of understanding, Research, DLS, Seafood, 3D, GCC, Shellfish, Salmon, Whitefish, Intellectual property, Marketing, Meat, Government, FPL, Red meat, Cryptocurrency

From forging strategic partnerships to securing substantial funding and making groundbreaking advancements in technology and intellectual property, 2023 has been a year of immense progress for Steakholder Foods.

Key Points: 
  • From forging strategic partnerships to securing substantial funding and making groundbreaking advancements in technology and intellectual property, 2023 has been a year of immense progress for Steakholder Foods.
  • Throughout 2023, Steakholder Foods achieved significant milestones and business highlights that underscore its leadership in the alternative protein industry.
  • Steakholder Foods signed a strategic agreement with a GCC governmental body, marking a significant milestone in international partnerships and expansion efforts.
  • In early 2024, Steakholder Foods signed an MoU with Wyler Farm, Israel largest tofu producer and one of its leading alternative protein producers.

Jinpeng Group Presents "Jinpeng to World" to the World at the 135th Spring Canton Fair

Retrieved on: 
Thursday, April 18, 2024
Sale, HS, 134th, Woman, DLS, Exclaim!, Canton Fair, XY

Xuzhou, China--(Newsfile Corp. - April 18, 2024) - The 135th Canton Fair opened on April 15, with a total exhibition area of 1.55 million square meters.

Key Points: 
  • Xuzhou, China--(Newsfile Corp. - April 18, 2024) - The 135th Canton Fair opened on April 15, with a total exhibition area of 1.55 million square meters.
  • Jinpeng Group was invited to participate in the first phase focusing on "advanced manufacturing" and showed the world the new Jinpeng "smart" manufacturing in Hall 8.1 and Hall 13.1.
  • This Jinpeng booth received a total of nearly 10,000 overseas buyers from the Philippines, Brazil, Denmark, France, Germany, Italy, Turkey, Russia and other countries and regions.
  • The main product of the Spring Canton Fair, the product was unanimously recognized by the vast number of overseas buyers as soon as it was exhibited.

Executive War College to Address, Clinical Laboratories’ and Genetic Testing Firms’ Perfect Storm, involving FDA’s Proposed LDT Rule, Payers Requiring Z-Codes on Genetic Test Claims, and Revisions to CLIA Regulations

Retrieved on: 
Friday, April 19, 2024
FDA, Health Technology, Publishing, Healthcare Reform, Communications, General Health, Medical Devices, Public Policy, Government, Genetics, Clinical Trials, Science, Biotechnology, Other Science, Health, Research, Dark, Storm, Organization, COLA, Leica Biosystems, Laboratory, Food, CDC, Cleveland Clinic, DLS, MD, Clinical Laboratory, Doctor of Philosophy, ISO, Pathology, Artificial intelligence, History, Genetic testing, ARUP Laboratories, CLIA, Marie Cassidy, Medical device, College, Multimedia, French Quarter, Division, IVD, Darkness

One is the Food and Drug Administration’s (FDA) proposed rule https://www.fda.gov/news-events/press-announcements/fda-proposes-rule-ai... to regulate laboratory developed tests (LDTs).

Key Points: 

Steakholder Foods Brings Sustainable Innovation to the U.S. with 3D-Printed Plant-Based Delicacies

Retrieved on: 
Wednesday, April 3, 2024
Health, Meat, Food technology, Red meat, FPL, 3D, Food, Seafood, DLS, Food safety, FSMA

REHOVOT, Israel, April 3, 2024 /PRNewswire/ -- Steakholder Foods Ltd. (Nasdaq: STKH), is excited to announce its innovative SHMeat and SHFish blends, designed for 3D-printing exquisite plant-based fish and steak alternatives.

Key Points: 
  • Fused Paste Layering (FPL): Used for meat production, ensuring that the fibrous texture of meat is accurately replicated in the plant-based products.
  • As Steakholder Foods makes its mark in the U.S. market, we are actively seeking partnerships with like-minded companies and producers.
  • Together, we can lead the charge in the food industry's evolution, offering consumers innovative, sustainable, and ethical food choices.
  • Our advanced 3D printing technologies are not just a testament to innovation but also a commitment to sustainability and health.

Steakholder Foods Receives Initial SIIRD Grant Payment

Retrieved on: 
Tuesday, March 12, 2024
Meat, White, DLS, IUCN, USD

REHOVOT, Israel, March 12, 2024 /PRNewswire/ -- Steakholder Foods Ltd. (Nasdaq: STKH), a pioneer in 3D-printed meat and fish technology and cultivated cell innovation, announced that it has received a first-phase payment of USD 220,000 from the Singapore-Israel Industrial R&D Foundation (SIIRD), out of a maximum USD 1,000,000 for the Company from SIIRD.

Key Points: 
  • Based on the successful development of 3D-printed hybrid grouper fish, Steakholder Foods has received an initial amount of $220,000 out of a $1,000,000 grant
    REHOVOT, Israel, March 12, 2024 /PRNewswire/ -- Steakholder Foods Ltd. (Nasdaq: STKH), a pioneer in 3D-printed meat and fish technology and cultivated cell innovation, announced that it has received a first-phase payment of USD 220,000 from the Singapore-Israel Industrial R&D Foundation (SIIRD), out of a maximum USD 1,000,000 for the Company from SIIRD.
  • Steakholder Foods has successfully 3D-printed hybrid fish that are comprised of Steakholder Foods' SHFish – White Fish™ plant-based raw material formulation, and cultivated grouper cells provided by Umami Bioworks and printed by Steakholder Foods' Drop Location in Space (DLS)™ printing technology.
  • Building on this success, Steakholder Foods intends to continue its innovative work under the SIIRD grant, including focusing on the development of a previously announced Japanese eel product.
  • Arik Kaufman, CEO of Steakholder Foods, said: "We believe that our initial SIIRD grant payment is indicative of non-dilutive funding sources that we hope to make available to Steakholder Foods in the foreseeable future, as our technologies continue to reach more advanced TRLs."

Group-IB reveals Hi-Tech Crime Trends 23/24: surge in ransomware against backdrop of growing AI, macOS threats

Retrieved on: 
Thursday, February 29, 2024
Lazarus, JavaScript, Research, DLS, Artificial intelligence, Image scaling, Attack, App Store (iOS/iPadOS), IOS, Growth, MacOS, Sale, Intelligence, Dropbox, Google Drive, Publishing, Government, ChatGPT, Risk, IAB, Threat intelligence, LLM, GPT, Android, Organization, Non-governmental organization, Voice over IP, MEA, Knowledge, Telecommunications, Telegraphy, APT, OneDrive, Law enforcement, Cryptocurrency

The growing appetite of nation-state sponsored threat actors, also known as advanced persistent threat (APT) groups, has shown that no region is immune to cyber threats.

Key Points: 
  • The growing appetite of nation-state sponsored threat actors, also known as advanced persistent threat (APT) groups, has shown that no region is immune to cyber threats.
  • FraudGPT and WormGPT are highly discussed tools on underground forums and Telegram channels, tailored for social engineering and phishing.
  • Group-IB's Hi-Tech Crime Trends 2023/2024 also highlighted the sale of compromised ChatGPT credentials on the dark web, building upon past research .
  • A full round-up of the top global threats and invaluable insights from the Group-IB Threat Intelligence unit can be found in the full Hi-Tech Crime Trends 2023/2024 report.

Group-IB reveals Hi-Tech Crime Trends 23/24: surge in ransomware against backdrop of growing AI, macOS threats

Retrieved on: 
Thursday, February 29, 2024
Lazarus, JavaScript, Multimedia, Research, DLS, Artificial intelligence, Image scaling, Attack, App Store (iOS/iPadOS), IOS, Growth, MacOS, Sale, Intelligence, Dropbox, Google Drive, Publishing, Government, ChatGPT, Risk, IAB, Threat intelligence, LLM, GPT, Android, Organization, Non-governmental organization, Voice over IP, MEA, Knowledge, Telecommunications, Telegraphy, APT, OneDrive, Law enforcement, Cryptocurrency

The growing appetite of nation-state sponsored threat actors, also known as advanced persistent threat (APT) groups, has shown that no region is immune to cyber threats.

Key Points: 
  • The growing appetite of nation-state sponsored threat actors, also known as advanced persistent threat (APT) groups, has shown that no region is immune to cyber threats.
  • FraudGPT and WormGPT are highly discussed tools on underground forums and Telegram channels, tailored for social engineering and phishing.
  • Group-IB's Hi-Tech Crime Trends 2023/2024 also highlighted the sale of compromised ChatGPT credentials on the dark web, building upon past research .
  • A full round-up of the top global threats and invaluable insights from the Group-IB Threat Intelligence unit can be found in the full Hi-Tech Crime Trends 2023/2024 report.

East Daley Analytics Releases 2024 Domestic Gas and Oil Industry Outlook

Retrieved on: 
Tuesday, December 12, 2023
Energy, Other Energy, Utilities, Oil, Gas, Permian, DLS, Entrepreneurship, NGL, MST, Annual report, Natural gas, Rare-earth element, Petroleum

East Daley Analytics released Dirty Little Secrets (DLS) 2024, its annual report that reveals insights into the evolving energy landscape and provides an outlook on the future dynamics of the North American oil and gas industry.

Key Points: 
  • East Daley Analytics released Dirty Little Secrets (DLS) 2024, its annual report that reveals insights into the evolving energy landscape and provides an outlook on the future dynamics of the North American oil and gas industry.
  • The report dissects the key elements shaping the industry by triangulating information across multiple commodities and combining commercial analytics, offering valuable perspectives and data-driven analyses through 2024.
  • “Current economic conditions, recent M&A activity and conflicts in the Middle East and Ukraine are leading to a volatile energy market in North America,” said Justin Carlson, Co-Founder and Chief Commercial Officer of East Daley Analytics.
  • This year’s report explores the following topics:
    Join East Daley Analytics for this webinar: Dirty Little Secrets: 2024 Domestic Oil & Gas Industry Outlook on December 13, 2023, at 10:00 am MST.

Fictiv Adds Carbon DLS™ to 3D Printing Service

Retrieved on: 
Wednesday, November 15, 2023
3D, DLS, Catalog, SAN, Engineering, CLIP, 3D printing, Carbon, Fictive art

This new offering follows a major 3D printing service expansion giving customers access to industrial additive solutions fit for advanced engineering and high-volume production applications.

Key Points: 
  • This new offering follows a major 3D printing service expansion giving customers access to industrial additive solutions fit for advanced engineering and high-volume production applications.
  • "The trend of using 3D printing to manufacture functional, end-use parts is on the rise," said Riley Hall, Director of Additive at Fictiv.
  • "Fictiv and Carbon share a mission to help businesses develop better products and bring them to market in less time," said Phillip Desimone, CEO at Carbon.
  • To learn more about Fictiv's Carbon DLS 3D printing service,  visit the company's website .

Innate Pharma Announces New Clinical Data for Lacutamab and SAR443579/IPH6101 at ASH 2023

Retrieved on: 
Friday, November 3, 2023
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, CR, Society for Hematology and Stem Cells, Acute lymphoblastic leukemia, Acute myeloid leukemia, Bone marrow, PTCL, CD123, PFS, Cohort, Skin, CRS, Complete Response Letter, Poster, IPH, Society, Notifiable disease, ASH, Euronext Paris, Abstract, Blood, ORR, CBR, IPHA, Safety, Exposition, DLS, AML, Pharmaceutical industry, Patient, Sanofi

Clinical Benefit Rate (CBR, defined as CR+PR+SD) was 87.5 % (n=49; 95% CI 76.4-93.8).

Key Points: 
  • Clinical Benefit Rate (CBR, defined as CR+PR+SD) was 87.5 % (n=49; 95% CI 76.4-93.8).
  • Continued evaluation of this promising new targeted treatment option for patients with Sezary Syndrome is warranted.
  • The poster will display preclinical combination data supporting anti-tumor activity and rationale for the exploration of lacutamab in combination with approved and novel therapies in patients with PTCL.
  • SAR443579 was well tolerated up to doses of 6000 μg/kg QW with observed clinical benefit in patients with R/R AML.